Loading…
Atlassian
NASDAQ: TEAM Technology IT 🔎 Screen
🏹 Trader: 🚀 Stage 2 + Near High 📈 Stage 2 🎯 Near 52W High 💎 VCP Breakout | BRS 86 Ready View all →
📈 Stage 2 detected Find the fundamental catalyst → → run Growth Triggers in Ask AI
$44.7B
Market Cap
1,295.0
P/E
0.59
PEG
-206.4%
ROCE
-4.5%
ROE
1.17
D/E
4.5%
OPM
-7.6%
% from 52W High
91
α RS
🔍 TEAM is showing a momentum setup because RS Rating is 91 (top decile vs market), an ECS of 62.2 last quarter, and it's within 7.6% of its 52-week high. Net: Broad signal stack, not a recommendation. ? RS Rating ECS 52W High
Sources
RS Rating 91 · ECS 62.2 · 7.6% from 52W high
⚖️ Compare 🔒 Generate Report 🔒 Research Packet 📚 Guides
🌏 Global Investor Returns
Currency-adjusted total returns for TEAM including FX impact
🌏
Click 🌏 Returns tab to load data
📈 Price History
Ratio Health
Excellent
Good
Average
Poor
By Category
📊 Sector Averages
About

Atlassian Corporation provides a collaboration software that enables organizations to connect all teams through a system of work that unlocks productivity at scale worldwide.

Key Ratios Snapshot
📈 Growth Pattern
📊 Quick Scorecard
Loading…
⭐ Superinvestors Holding TEAM
View All Superinvestors →
Manager Shares Value % of Fund Period
Jim Simons Renaissance Technologies LLC 495.2K $33.8M 0.05% Mar 2026

SEC Form 13F data. 45-day lag from quarter end.

🔒
Premium Feature
AI-generated 10-section company profile — business model, financials, strengths, risks & management quality
Upgrade to Premium
Already a member? Log in
📐
3-Statement Financial Model
Bear / Base / Bull projections · DCF fair value · Reverse-DCF
Open Model →
🎙 Management Tone Confident Specific → Stable 5 quarters Full tone analysis in Intelligence →
Good quarter Investor Presentation One-Pager? Q4 2026
Revenue
$1.8B
+28% YoY
Operating Income
$211M
Improved from -$28M YoY
Operating Margin
12%
+14pp YoY
Net Income
$139M
Improved from -$24M YoY
What Went Right
  • Cloud revenue growth accelerated to 31% YoY, reaching $1.2B, with Subscription ARR up 23% to $6.606B.
  • Record enterprise quarter: $3M+ ARR customers grew over 50% YoY and $5M+ ARR customers grew over 70% YoY; RPO rose 44% to $4.8B.
  • Rovo is now used by over 80% of the Fortune 500, Rovo-assisted actions grew 50% QoQ, and MCP/CLI users surpassed 1 million, more than doubling in the quarter.
What to Watch
  • FY2027 Subscription ARR growth is guided to ~18%, down from 23%, reflecting an approximate 1-point drag from lapping the DX acquisition plus management's prudent macro/geopolitical stance.
  • Management guided Q1 FY27 GAAP operating margin to 6.5% and FY27 GAAP operating margin to 4.5%, a notable step-down from Q4's 12% as AI and enterprise investments continue.
  • AI cost-to-serve remains a challenge; management highlighted model blending and token management as ongoing work, though it saw strong leverage in the quarter.
Management Guidance
  • Subscription ARR growth guided to ~18% for FY2027.
  • Q1 FY2027 GAAP operating margin guided to 6.5%.
  • FY2027 GAAP operating margin guided to 4.5%.
  • No explicit revenue guidance range was provided on the call.
Investor Lens
The thesis is stronger after this call: cloud growth accelerated, large-deal cohorts surged, RPO grew 44%, and Rovo adoption is broadening. Management guided FY27 subscription ARR growth to ~18% largely due to prudence and the DX acquisition lap, not apparent demand deterioration. The main near-term watch is the guided step-down in GAAP operating margins from 12% in Q4 to 4.5% for FY27 as AI and enterprise investments continue.
From investor presentation · AI-generated analysis · Not investment advice
🔒
Premium Feature
Investor Presentation One-Pager — quarterly highlights, what went right/wrong & management guidance
Upgrade to Premium
Already a member? Log in
📈 STRONG Q4 delivered 28% revenue growth and 12% GAAP operating margin.
Revenue
Total revenue was $1.766 billion in Q4 FY26, up 28% year-over-year. Cloud revenue grew 31% to $1.213 billion, while Subscription ARR reached $6.606 billion, up 23%.
Profitability
GAAP net income was $139 million versus a net loss of $24 million in the prior-year quarter, with GAAP diluted EPS of $0.55. Non-GAAP net income was $473 million, or $1.87 per diluted share, versus $259 million, or $0.98, a year ago.
Margins
GAAP operating margin improved to 12% from -2% in Q4 FY25, while non-GAAP operating margin expanded to 36% from 24%. Management credited disciplined hiring, lower stock-based compensation, and strong AI cost-to-serve management, including model blending.
Balance Sheet
Cash and cash equivalents totaled $1.240 billion at quarter-end. Q4 operating cash flow was $479 million and free cash flow was $475 million, representing a 27% free cash flow margin.
Key Risks
Management flagged macro, fiscal policy, and geopolitical uncertainty as reasons for prudent FY27 guidance. The lap of the DX acquisition will reduce reported ARR growth by roughly one point. Analysts also pressed on AI-driven margin pressure and AI cost-to-serve, though management said the architecture is holding up well.
Outlook
For FY2027, management guided Subscription ARR growth to approximately 18%. Q1 FY27 GAAP operating margin is guided to 6.5%, and FY27 GAAP operating margin is guided to 4.5%.
Generated by AI · Q4 2026 results · Not investment advice
🔒
Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free AccountLog In
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Ask AI.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to PremiumCreate Free Account
✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter
🔍
🔎 See cross-company document search → ?
📞 Earnings Call Transcripts (5)
Q4 2026 Q4 2026 2026-08-06
Q4 FY 2026 saw 28% revenue growth and record enterprise deals, with cloud revenue up 31% and RPO up 44%. AI adoption surged, driving seat expansion and higher NRR, while FY 2027 guidance reflects prudent optimism amid macro uncertainty.
Q3 2026 Q3 2026 2026-04-30
Q3 FY26 saw 32% revenue growth to $1.8B, with Cloud revenue up 29% and RPO at $4B. AI-driven products like Rovo fueled ARR growth, while Service Collection surpassed $1B ARR and competitive wins hit record highs.
Q2 2026 Q2 2026 2026-02-05
Q2 saw record Cloud revenue, strong enterprise adoption, and rapid AI-driven seat expansion, with RPO up 44% year-over-year and NRR above 120%. Management reaffirmed 20%+ revenue CAGR through FY 2027 and accelerated share buybacks.
Q1 2026 Q1 2026 2025-10-30
Q1 FY26 saw 21% revenue growth and 26% cloud revenue growth, driven by strong AI adoption and accelerated data center to cloud migrations. Guidance was raised for cloud revenue, with long-term targets reaffirmed and robust enterprise momentum.
Q4 2025 Q4 2025 2025-08-07
FY 2025 delivered strong revenue and free cash flow growth, with record enterprise deals and rapid AI adoption. Outlook remains robust, targeting 20% CAGR through FY 2027, with continued investment in AI, cloud, and enterprise transformation.
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Catalyst Timeline.

Every result, order win, insider trade, ECS update, earnings-call, and SEC announcement for this company — in one chronological lane.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Full Report.

Read the complete Finmagine™ investment research report — comprehensive fundamental analysis, business model assessment, competitive positioning, and investment recommendation.

Upgrade to PremiumCreate Free Account

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

Financial Model
Projections are built from each company's audited annual financials (Income Statement, Balance Sheet, Cash Flow) over the last 5 fiscal years. Forward assumptions — revenue growth %, EBITDA margin, D&A (USD millions), interest expense, tax rate, and capex — are AI-generated using historical context and refreshed twice a year: after the December results season and after the September/Q4 results season.

DCF Valuation
Fair Value = Σ(FCFt / (1+WACC)t) + Terminal Value. Terminal Value uses the Gordon Growth Model: FCF5 × (1+g) / (WACC−g). Default WACC: 10% (US risk-free ~4.5%, equity risk premium ~5.5%). Default terminal growth: 3% (long-run US nominal GDP proxy).

CAGR Tracker
Expected 5-year CAGR = (DCF Fair Value / Current Price)1/5 − 1. Assumes fair value is reached in exactly 5 years — a mechanical estimate only.

Data Sources & Limitations
Financial statements sourced from public filings. Prices updated daily. Forward assumptions are AI-generated. All monetary values in USD millions. Non-US ADR companies may have currency conversion inaccuracies. Models are point-in-time and do not update intra-quarter or account for M&A, macro shocks, or extraordinary items.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.